TB-500 10 mg + BPC-157 10 mg + KPV 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 600 mcg | daily | 0.06 mL | 6 u | 14 | 8.4 mg |
| Weeks 3–4 | 900 mcg | daily | 0.09 mL | 9 u | 14 | 12.6 mg |
| Week 5 onward per 4 weeks from here on |
1500 mcg | daily | 0.15 mL | 15 u | 28 | 42 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Low reported | 600 mcg | 1× daily · 200 mcg of each compound | 0.06 mL | 6 u | 50 doses |
| Standard | 900 mcg | 1× daily · 300 mcg of each compound | 0.09 mL | 9 u | 33 doses |
| Upper reported | 1500 mcg | 1× daily · 500 mcg of each compound | 0.15 mL | 15 u | 20 doses |
An equal-thirds repair and anti-inflammatory combination — 10 mg of each component in a 30 mg vial. Because the three are pooled at a fixed 1:1:1 ratio you cannot move one without moving the others, so every dose delivers exactly one third of the total to each. A 900 mcg dose is 300 mcg apiece.
Buy TB-500 / BPC-157 / KPV BlendPaid affiliate links.
Adding 3 mL of bacteriostatic water to a 30 mg vial gives 10 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for TB-500 / BPC-157 / KPV Blend run from 600 mcg to 1500 mcg, typically 1× daily (200 mcg each). This site lists each figure with the source it came from rather than giving a single recommended number.
At 10 mg/mL, a 600 mcg dose is 6 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 50 doses.
TB-500 / BPC-157 / KPV Blend is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
This is the BPC-157 / KPV pairing with TB-500 added. Repair, anti-inflammatory activity and remodelling in one vial, at an even 10 mg of each.
It sits between the two-compound repair blends and the GHK-Cu-heavy GLOW family: no cosmetic component, but broader repair coverage than either two-compound blend on its own.
Compounds in the same class, or browse the full catalogue.
An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…
A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistic…
Every compound compared in one table: dose range, how often, half-life and evidence tier.
Need this on one page to print, screenshot or send?
Make a dose card →